Potential Neuroprotective Effects of Adiponectin in Alzheimer's Disease

Int J Mol Sci. 2017 Mar 9;18(3):592. doi: 10.3390/ijms18030592.

Abstract

The adipocyte-secreted protein adiponectin (APN) has several protective functions in the peripheral tissues including insulin sensitizing, anti-inflammatory and anti-oxidative effects that may benefit neurodegenerative diseases such as Alzheimer's disease (AD). In addition, dysregulation of cerebral insulin sensitivities and signaling activities have been implicated in AD. Emerging insights into the mechanistic roles of adiponectin and AD highlight the potential therapeutic effects for AD through insulin signaling.

Keywords: Alzheimer’s disease; Amyloid-β; adiponectin; cognitive impairments.

Publication types

  • Review

MeSH terms

  • Adipocytes / drug effects
  • Adipocytes / metabolism
  • Adiponectin / genetics
  • Adiponectin / metabolism*
  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / metabolism*
  • Animals
  • Humans
  • Neuroprotective Agents / pharmacology
  • Neuroprotective Agents / therapeutic use
  • PPAR gamma / agonists
  • PPAR gamma / metabolism

Substances

  • Adiponectin
  • Neuroprotective Agents
  • PPAR gamma